logo

For the Inventor, By the Inventor

West Newton, MA, United States of America

C Ronald Kahn

This inventor holds 16 USPTO granted patents and 8 published patent applications, primarily in Diabetes Treatment. Top assignees: Joslin Diabetes Center, Inc., Children's Hospital Boston, Children's Medical Center Corporation. Active years: 1993-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: C Ronald Kahn. Retrieved from https://idiyas.com/inventor/c-ronald-kahn

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 16 

% Patents Active = 68.8

Average Co-Inventor Count = 2.3

ph-index = 4

Forward Citations = 100(Granted Patents)


Location History:

  • West Newton, MA (US) (1993 - 2016)
  • Newton, MA (US) (2017)
  • Falls Church, VA (US) (2022)

Company Filing History:

goldMedal16 out of 76 
 
Joslin Diabetes Center, Inc.
 patents
silverMedal2 out of 9 
 
Children's Hospital Boston
 patents
bronzeMedal2 out of 1,076 
 
Children's Medical Center Corporation
 patents
4. 1 out of 3,081 
 
Harvard College
 patents
where one patent can have more than one assignee

Years Active: 1993-2026

Loading Chart...
Areas of Expertise:
Micro-RNAs
Exosomal Delivery
Chemical Screening
Glypican-4
Adipogenesis
Adipocyte Function
Diabetes Risk
Insulin Resistance
Frataxin Gene
Insulin Receptor
Type I Diabetes
Type II Diabetes
16 patents (USPTO):Explore Patents
1. 12559746 - Targeting Micro-RNAs for Exosomal Delivery or Cellular Retention (2026-02-24),
2. 11519008 - Exosome delivery system (2022-12-06),
3. 9771560 - High-throughput image-based chemical screening in zebrafish blastomere cell culture (2017-09-26),
4. 9446096 - Glypican-4 based compositions and methods for treating and diagnosing insulin resistance (2016-09-20),
5. 9346869 - Methods and compositions for inducing brown adipogenesis (2016-05-24),
6. 9132169 - Methods and compositions for modulating adipocyte function (2015-09-15),
7. 8178492 - Methods and compositions for modulating adipocyte function (2012-05-15),
8. 7825098 - Methods and compositions for modulating Necdin function (2010-11-02),
9. 7700555 - Methods of treating diabetes (2010-04-20),
10. 7576052 - Methods and compositions for modulating adipocyte function (2009-08-18),
11. 6326141 - Methods for determining risk for Type I and Type II diabetes (2001-12-04),
12. 6322978 - Repeat polymorphism in the frataxin gene and uses therefore (2001-11-27),
13. 5891430 - Diabetogene rad: a type II diabetes specific gene (1999-04-06),
14. 5621075 - Insulin receptor substrate (1997-04-15),
15. 5589374 - Diabetogene rad: a type II diabetes specific gene (1996-12-31),

Title: The Innovative Journey of C. Ronald Kahn

Introduction: C. Ronald Kahn, a distinguished inventor hailing from West Newton, MA (US), has made significant contributions to the field of science and technology through his groundbreaking inventions.

Latest Patents: C. Ronald Kahn holds several patents in the field of biotechnology and medical research, focusing on innovative solutions for diabetes treatment and metabolic disorders.

Career Highlights: With a career spanning several decades, C. Ronald Kahn has served as a leading researcher and professor at prestigious institutions such as Harvard Medical School and the Joslin Diabetes Center. His work has been pivotal in advancing our understanding of insulin signaling and its implications for various health conditions.

Collaborations: Throughout his career, C. Ronald Kahn has collaborated with top scientists, researchers, and medical professionals worldwide to further the development of cutting-edge technologies in the healthcare industry. His collaborative efforts have led to groundbreaking discoveries and advancements in the field.

Conclusion: In conclusion, C. Ronald Kahn's relentless pursuit of innovation and his dedication to improving healthcare have solidified his reputation as a pioneering inventor in the realm of biotechnology. His work continues to inspire future generations of inventors and researchers to push the boundaries of what is possible in the world of science and technology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…